什么是 SEC Form 13F 申报?美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
CIK: 0001674546
申报总市值
US$47.5亿
US$47.5亿
163 檔
29.3%
截至 Q3 2024 季度末,Bellevue Group AG 的美股持仓估值约为 US$47.5亿,全数申报仓位共有 163 档。
Bellevue Group AG 在 Q3 2024 进行了结构性的板块轮动与仓位换股。在开立 12 个全新仓位及加仓 57 档持股的同时,亦同步清仓 15 档并减仓 71 档标的。
在资产配置集中度方面,Bellevue Group AG 的前 5 大核心持股(包含 ARGX, IONS, VRTX 等)合计占整体申报市值的 29.3%,反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 5.56% | +0.44% | -8.53% | |
| 2 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 5.11% | -1.63% | -4.67% | |
| 3 | VRTX | Vertex Pharmaceuticals Inc | 股票-医疗保健 | 4.31% | -1.20% | -3.72% | |
| 4 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 3.95% | -1.01% | -7.99% | |
| 5 | ALNY | Alnylam Pharmaceuticals Inc | 股票-医疗保健 | 3.61% | -1.84% | -12.04% | |
| 6 | RVMD | Revolution Medicines Inc | 股票-医疗保健 | 3.58% | +0.56% | -3.14% | |
| 7 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 3.48% | +0.08% | -1.83% | |
| 8 | BSX | Boston Scientific CORP | 股票-医疗保健 | 3.33% | -1.39% | -4.55% | |
| 9 | ABT | Abbott Laboratories | 股票-医疗保健 | 3.22% | -1.00% | +8.58% | |
| 10 | SYK | Stryker CORP | 股票-医疗保健 | 3.08% | +0.08% | -3.54% | |
| 11 | ITCIEUR | Intra-cellular Therapies Inc | 股票-其他 | 2.95% | — | +0.58% | |
| 12 | AGIO | Agios Pharmaceuticals Inc | 股票-其他 | 2.69% | — | -3.70% | |
| 13 | INCY | Incyte CORP | 股票-医疗保健 | 2.30% | — | -0.14% | |
| 14 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 2.14% | +0.35% | +9.66% | |
| 15 | MRNA | Moderna Inc | 股票-医疗保健 | 1.73% | — | +2.37% | |
| 16 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.69% | +0.03% | +3.37% | |
| 17 | BHVN | Biohaven Ltd. | 股票-其他 | 1.65% | — | — | |
| 18 | EXK | Exact Sciences CORP | 股票-原材料 | 1.60% | — | +25.07% | |
| 19 | CDNA | Caredx Inc | 股票-其他 | 1.59% | — | -19.61% | |
| 20 | PODD | Insulet CORP | 股票-医疗保健 | 1.59% | -0.41% | -3.20% | |
| 21 | MDT | Medtronic plc | 股票-医疗保健 | 1.47% | -0.33% | +0.69% | |
| 22 | BDX | Becton Dickinson And Co | 股票-医疗保健 | 1.32% | -0.11% | -2.79% | |
| 23 | TNDM | Tandem Diabetes Care Inc | 股票-其他 | 1.27% | — | +19.93% | |
| 24 | EVH | Evolent Health Inc - A | 股票-其他 | 1.22% | — | +59.90% | |
| 25 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 1.21% | -0.19% | -10.03% | |
| 26 | DXCM | Dexcom Inc | 股票-医疗保健 | 1.10% | -0.01% | -19.84% | |
| 27 | ARVN | Arvinas Inc | 股票-其他 | 0.95% | — | -0.18% | |
| 28 | PEN | Penumbra Inc | 股票-医疗保健 | 0.86% | -0.10% | EXIT | |
| 29 | RLAY | Relay Therapeutics Inc | 股票-其他 | 0.85% | +0.59% | +15.68% | |
| 30 | OPCH | Option Care Health Inc | 股票-医疗保健 | 0.84% | — | +16.80% | |
| 31 | GEHC | GE Healthcare Technology | 股票-医疗保健 | 0.81% | -0.37% | +2.10% | |
| 32 | PRCT | Procept Biorobotics CORP | 股票-其他 | 0.80% | -0.06% | -8.42% | |
| 33 | EPIEUR | Essa Pharma Inc | 股票-其他 | 0.77% | — | -0.13% | |
| 34 | ZBH | Zimmer Biomet Holdings Inc | 股票-医疗保健 | 0.76% | -0.10% | -3.62% | |
| 35 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 0.75% | -0.24% | -6.36% | |
| 36 | ELV | Elevance Health Inc | 股票-医疗保健 | 0.75% | +0.09% | -12.03% | |
| 37 | IDXX | Idexx Laboratories Inc | 股票-医疗保健 | 0.75% | -0.51% | -2.23% | |
| 38 | COO | Cooper Cos Inc/the | 股票-医疗保健 | 0.71% | -0.16% | — | |
| 39 | SRPT | Sarepta Therapeutics Inc | 股票-医疗保健 | 0.70% | — | +36.47% | |
| 40 | EXEL | Exelixis Inc | 股票-医疗保健 | 0.67% | — | -11.27% | |
| 41 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 0.67% | -0.12% | EXIT | |
| 42 | CI | THE Cigna Group | 股票-医疗保健 | 0.66% | -0.23% | -3.80% | |
| 43 | LLY | Eli Lilly & Co | 股票-医疗保健 | 0.64% | +0.01% | -10.93% | |
| 44 | RMD | Resmed Inc | 股票-医疗保健 | 0.63% | -0.24% | +2.72% | |
| 45 | INSM | Insmed Inc | 股票-医疗保健 | 0.62% | +3.09% | -48.57% | |
| 46 | EWTX | Edgewise Therapeutics Inc | 股票-其他 | 0.62% | -1.15% | EXIT | |
| 47 | IMCR | Immunocore Holdings Plc-adr | 股票-其他 | 0.61% | -0.15% | +4.40% | |
| 48 | BEAM | Beam Therapeutics Inc | 股票-其他 | 0.60% | — | +7.05% | |
| 49 | BDTX | Black Diamond Therapeutics I | 股票-其他 | 0.60% | — | — | |
| 50 | ALGN | Align Technology Inc | 股票-医疗保健 | 0.59% | -0.07% | +0.01% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | EXK | Exact Sciences CORP | +0.8% | +25.07% | 加仓 |
| 2 | ARGX | Argenx Se - Adr | +0.7% | -8.53% | 减仓 |
| 3 | EVH | Evolent Health Inc - A | +0.7% | +59.90% | 加仓 |
| 4 | CDNA | Caredx Inc | +0.6% | -19.61% | 减仓 |
| 5 | ABT | Abbott Laboratories | +0.5% | +8.58% | 加仓 |
| 6 | BHVN | Biohaven Ltd. | +0.5% | — | 不变 |
| 7 | UNH | Unitedhealth Group Inc | +0.4% | +9.66% | 加仓 |
| 8 | RVMD | Revolution Medicines Inc | +0.4% | -3.14% | 减仓 |
| 9 | INSP | Inspire Medical Systems Inc | +0.4% | +56.41% | 加仓 |
| 10 | BMRN | Biomarin Pharmaceutical Inc | +0.3% | +533.67% | 加仓 |
| 11 | VRNA | Verona Pharma PLC - Adr | +0.3% | +7.57% | 加仓 |
| 12 | TNDM | Tandem Diabetes Care Inc | +0.3% | +19.93% | 加仓 |
| 13 | WVE | Wave Life Sciences Ltd. | +0.2% | — | 不变 |
| 14 | ITCIEUR | Intra-cellular Therapies Inc | +0.2% | +0.58% | 加仓 |
| 15 | OPCH | Option Care Health Inc | +0.2% | +16.80% | 加仓 |
| 16 | EWTX | Edgewise Therapeutics Inc | +0.2% | — | 不变 |
| 17 | MDT | Medtronic plc | +0.2% | +0.69% | 加仓 |
| 18 | INCY | Incyte CORP | +0.2% | -0.14% | 减仓 |
| 19 | IQV | Iqvia Holdings Inc | +0.2% | +40.99% | 加仓 |
| 20 | RLAY | Relay Therapeutics Inc | +0.2% | +15.68% | 加仓 |
| 21 | PODD | Insulet CORP | +0.2% | -3.20% | 减仓 |
| 22 | TMO | Thermo Fisher Scientific Inc | +0.2% | +25.80% | 加仓 |
| 23 | ONC | Beone Medicines Ltd-adr | +0.2% | +129.15% | 加仓 |
| 24 | CSTL | Castle Biosciences Inc | +0.2% | +3.69% | 加仓 |
| 25 | GEHC | GE Healthcare Technology | +0.2% | +2.10% | 加仓 |
| 26 | RMD | Resmed Inc | +0.2% | +2.72% | 加仓 |
| 27 | COO | Cooper Cos Inc/the | +0.2% | — | 不变 |
| 28 | 430 | Terns Pharmaceuticals Inc | +0.1% | NEW | 新建仓 |
| 29 | DHR | Danaher CORP | +0.1% | +25.82% | 加仓 |
| 30 | PRCT | Procept Biorobotics CORP | +0.1% | -8.42% | 减仓 |
| 31 | NEO | Neogenomics Inc | +0.1% | +34.15% | 加仓 |
| 32 | BSX | Boston Scientific CORP | +0.1% | -4.55% | 减仓 |
| 33 | HCA | Hca Healthcare Inc | +0.1% | -6.36% | 减仓 |
| 34 | JNJ | Johnson & Johnson | +0.1% | +557.20% | 加仓 |
| 35 | EPIEUR | Essa Pharma Inc | +0.1% | -0.13% | 减仓 |
| 36 | GPCR | Structure Therapeutics Inc | +0.1% | +13.00% | 加仓 |
| 37 | ANNX | Annexon Inc | +0.1% | — | 不变 |
| 38 | ASTH | Astrana Health Inc | +0.1% | +1.42% | 加仓 |
| 39 | SYK | Stryker CORP | +0.1% | -3.54% | 减仓 |
| 40 | BEAM | Beam Therapeutics Inc | +0.1% | +7.05% | 加仓 |
| 41 | VEEV | Veeva Systems Inc-class A | +0.1% | -3.01% | 减仓 |
| 42 | ISRG | Intuitive Surgical Inc | +0.1% | -7.99% | 减仓 |
| 43 | SRPT | Sarepta Therapeutics Inc | +0.1% | +36.47% | 加仓 |
| 44 | OMCL | Omnicell Inc | 0% | -16.00% | 减仓 |
| 45 | SIBN | Si-bone Inc | 0% | +4.07% | 加仓 |
| 46 | PEN | Penumbra Inc | 0% | -3.32% | 减仓 |
| 47 | STE | STERIS plc | 0% | — | 不变 |
| 48 | BMY | Bristol-myers Squibb Co | 0% | NEW | 新建仓 |
| 49 | ALGN | Align Technology Inc | 0% | +0.01% | 加仓 |
| 50 | HO1 | Hologic Inc | 0% | +0.02% | 加仓 |
根据 SEC 官方 Form 13F 申报备案,Bellevue Group AG 在 Q3 2024 季度的美股持仓总市值约为 US$47.5亿,共申报了 163 个公开持股仓位。
在 Q3 2024 季度,Bellevue Group AG 按市值排列的前三大核心持股分别为:ARGX (5.6%)、IONS (5.1%)、VRTX (4.3%)。其中最大持股仓位 ARGX 占据整体投资组合约 5.6% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析,提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
430
市值: US$869.1万
本季最大获利了结 / 清仓标的
SILKUSD
前期市值: US$2312.7万
在 Q3 2024 季度中,Bellevue Group AG 共进行了 155 项持仓异动,包含新建仓 12 个仓位、加仓 57 个仓位、减仓 71 个仓位以及清仓 15 个仓位。 其中最大新建仓标的为 430。 本季清仓仓位包含 SILKUSD。
本页面所有持股数据均直接同步自美国证券交易委员会(SEC)EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照,提供 100% 精准对齐的历史时序数据集,并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报,掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异,以及最新 SEC 申报时程规范,洞察机构法人的激进投资动向。